EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
21,684,000
Total 13F shares
10,719,847
Share change
-1,043,949
Total reported value
$277,184,000
Price per share
$5.74
Number of holders
43
Value change
-$6,862,755
Number of buys
16
Number of sells
35

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2022

As of 30 Jun 2022, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,719,847 shares. The largest 10 holders included HighTower Trust Services, LTA, COWEN AND COMPANY, LLC, Stonepine Capital Management, LLC, RTW INVESTMENTS, LP, WASATCH ADVISORS INC, MORGAN STANLEY, SILVERCREST ASSET MANAGEMENT GROUP LLC, VANGUARD GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, and PERKINS CAPITAL MANAGEMENT INC. This page lists 43 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.